Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |